Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

NCT06610734 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer Extensive Stage

Interventions

DRUG: Adebrelimab
DRUG: Chemotherapy
RADIATION: low dose radiotherapy

Sponsor

Sichuan University

Collaborators

[object Object]